← Open Payments lookup

LAURA MIZELL: Open Payments

NPI 1457892648 · MONTGOMERY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,179 in 122 payments from 22 companies in 2025. Trend: 2023 $1,857 · 2024 $1,943 · 2025 $2,179

Food & beverage: $2,179
CompanyPaymentsAmount
Novo Nordisk Inc21$403
GlaxoSmithKline, LLC.13$245
AstraZeneca Pharmaceuticals LP11$227
Amgen Inc.10$158
Bayer Healthcare Pharmaceuticals Inc.7$146
Lilly USA, LLC11$142
Sumitomo Pharma America, Inc.8$131
PFIZER INC.5$119
Exact Sciences Corporation6$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$91

Products named: Wegovy, Ozempic, Kerendia, SHINGRIX, GEMTESA, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit.

Industry payments across TX — which companies pay providers there.